基因检测指导P2Y12受体拮抗剂个体化治疗的药物经济学研究进展

Research progress of pharmacoeconomics of individualized treatment of P2Y12 receptor antagonists guided by gene detection

本文通过检索近5年来的Pub Med,对以基因检测为指导的P2Y12受体拮抗剂个体化治疗的药物经济学研究进行整理归纳。探讨以基因检测为指导的P2Y12受体拮抗剂个体化治疗的药物经济学研究进展,为患者个体化抗血小板治疗提供参考,并结合现状给出相关结论与建议。

This article aims to explore the research progress of pharmacoeconomics of individualized treatment of P2Y12 receptor antagonists guided by gene detection through searching PubMed in the past five years to summarize the pharmacoeconomic researches about individualized treatment of P2Y12 receptor antagonists guided by gene testing,and to provide references for individualized antiplatelet therapy,and to propose relevant conclusions and suggestions by combining with the current situation.